Amylyx Pharmaceuticals, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5
Rok finansowy 2019 2020 2021 2022 2023 2024
Przychód (mln) 1 1 0 22 381 87
Przychód Δ r/r 0.0% -54.4% -56.2% 7700.0% 1612.9% -77.1%
Marża brutto -734.4% -3683.7% 81.8% 86.5% 93.3% 51.8%
EBIT (mln) -14 -39 -83 -201 39 -315
EBIT Δ r/r 0.0% 187.8% 112.0% 143.5% -119.3% -911.1%
EBIT (%) -950.5% -6000.8% -29013.3% -905.7% 10.2% -360.2%
Koszty finansowe (mln) 1 2 0 4 0 0
EBITDA (mln) -13 -39 -83 -201 40 -291
EBITDA(%) -938.2% -5957.1% -29013.3% -905.7% 10.5% -333.0%
Podatek (mln) 1 3 -0 1 5 -0
Zysk Netto (mln) -15 -45 -88 -198 49 -302
Zysk netto Δ r/r 0.0% 202.6% 96.0% 125.7% -124.8% -712.4%
Zysk netto (%) -1039.0% -6898.0% -30834.7% -892.4% 12.9% -345.4%
EPS -0.26 -0.79 -1.52 -2.98 0.73 -4.43
EPS (rozwodnione) -0.26 -0.79 -1.52 -2.98 0.7 -4.43
Ilośc akcji (mln) 56 56 58 67 67 68
Ważona ilośc akcji (mln) 56 56 58 67 70 68
Waluta USD USD USD USD USD USD